BEN-MAIMON CAROLE

LRMR

BEN-MAIMON CAROLE serves as President and CEO at Larimar Therapeutics, Inc. (LRMR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$118.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$118.5K

Companies Traded

LRMR

Active Period

Sep 2022 – May 2023

2 total trades

Most Recent

Buy LRMR

May 18, 2023 · $18.5K

BEN-MAIMON CAROLE's Insider Trading at Larimar Therapeutics, Inc. (LRMR)

Buys

2 · $118.5K

Sells

0 · $0.00

Total Shares Bought

36,746

Total Shares Sold

LRMR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 18, 2023	Buy	5,000	$3.71	$18.5K	266,829
Sep 19, 2022	Buy	31,746	$3.15	$100.0K	56,829

Related Insiders

James E Flynn

director, 10 percent owner, other: * Director by Deputization

LRMRBuy · Mar 2, 2026

Thomas Edward Hamilton

director

LRMRBuy · Mar 2, 2026

SHERMAN JEFFREY W

director

LRMRBuy · Mar 2, 2026

THOMAS FRANK E

director

LRMRBuy · Mar 2, 2026

Explore More Insider Trading Data

LRMR Insider Trading Activity

View all insider trades at Larimar Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity